Introduction
Postpolio-syndrome (PPS) is a neurologic disorder characterized by a collection of late manifestations occurring many years after the initial poliomyelitis infection. New or increased muscle weakness is the hallmark. The other clinical features are fatigue, pain in joints, bones and muscles, cold intolerance and bulbar symptoms (swallow, speech, respiratory symptoms). Fatigue has been described as the most common symptom. PPS symptoms affect the ability to perform the activities of daily living, mobility, upper limb function, and respiratory capacity. PPS has a negative effect on quality of life (QoL). [1] [2] [3] The present study aimed to investigate QoL in polio survivors in Turkey, to assess the impact of PPS on various QoL domains in terms of functional status, severity of pain, social and emotional functioning.
Material and methods
The study included a total of 40 polio survivors (21 men, 19 women) who were followed at the outpatient clinic of physical medicine and rehabilitation department of a training and research Hospital which is a major referral center under Ministry of Health, located in Ankara, capital city of Turkey, between December 2012 and September 2013. Study was conducted in accordance with the principles set forth in the Helsinki Declaration 2008.
67.5% of polio survivors (21 patients) fulfilling the Halstead's PPS criteria 4 participated in PPS group, and the remaining 19 polio survivors without PPS formed non-PPS group. Halstead's PPS criteria are: (1) a confirmed history of acute poliomyelitis affecting lower limbs; (2) partial or complete neurological and functional recovery after acute poliomyelitis; (3) new symptoms (extensive fatigue, muscle pain and/or joint pain, new muscle weakness in the muscles previously affected or unaffected) after a stable period of at least 15 years; (4) exclusion of other medical conditions that may explain these symptoms. 4 Isometric muscle strength was measured by manual muscle testing (MMT) according to Medical Research Council (MRC) Scale. 5 Hip flexors, knee extensors, knee flexors, ankle dorsal flexor and ankle plantar flexors were evaluated bilaterally, then total score was obtained (maximum score: 50).
Control group consisted of 40 age and sex matched healthy subjects (20 men, 20 women) whose total MMT scores were 50. Inclusion criteria for all subjects were no other disorders including fibromyalgia, hypertension, diabetes mellitus, hepatic and renal diseases, inflammatory arthritis, other neurological or psychiatric disorders that may cause fatigue.
Symptoms including muscle pain, fatigue, joint pain, sleep disorders, respiratory disorders and dysphagia were analyzed in PPS and non-PPS groups. QoL was assessed by Nottingham Health Profile (NHP) 6 and depression by using Beck Depression Scale (BDS). 7 Fatigue was evaluated by using Turkish version of Fatigue Symptom Inventory (FSI). 8 FSI, first published in 1998, is a 14-item self-report measure designed to assess fatigue intensity (four items), duration (two items), its interference with quality of life (7 items), and the daily pattern of fatigue. Intensity is measured on separate 11-point scales (0 = not at all fatigued; 10 = extreme fatigue) that assess most, least, current fatigue and average fatigue in the previous week. Each of these is scored as an individual item. The interference items assess the extent to which fatigue interfered with a respondent's general activity level, ability to bathe and dress, work activity, ability to concentrate, relations with others, enjoyment of life and mood during the previous week using an 11 point rating scale (0 = no interference and 10 = extreme interference). These 7 items are averaged to obtain an interference scale score. Duration items (number of days fatigued, amount of time fatigued) assess fatigue frequency. It is measured as the number of the days (from 0 to 7 days) in the past week that respondents felt fatigued and the amount of each day on average respondents felt fatigued (0 = none of the day, 10 = the entire day). Each of these is scored as an individual item. The final item asks respondents to indicate their daily pattern of fatigue and so provides descriptive information about possible diurnal variation in the daily experience of fatigue (0 = not at all fatigued, 1 = worse in the morning, 2 = worse in the afternoon, 3 = worse in the evening, 4 = no consistent daily pattern of fatigue). Final item provides information only and is not intended to be used as a quantitative scale. [9] [10] [11] The items included in the FSI are shown in Appendix 1.
Statistical analyses
Data were presented by descriptive analysis with means ± standard deviation (SD) and median scores. Because variables were not normally distributed, Kruskal-Wallis and Mann-Whitney U tests were performed to assess statistically significant differences in MMT, BDS, FSI and NHP scores of the groups. Categorical variables were evaluated by Chi-square test. A value of p < 0.05 was considered statistically significant. All analyses were performed using Statistical Package for the Social Sciences -13.0 (SPSS-13.0) software.
Results
Demographic and clinical characteristics of the patients and control subjects are summarized in Table 1 . Mean age was 38.15 ± 7.17 in PPS group, 37 ± 4.86 in non-PPS group and 35 ± 8.42 in the control group. At the time of acute polio, polio survivors were 19.2 ± 12.23 months old on average (3 months to 4 years, median: 18 months).
Of the patients in PPS group, 12 had paralyses of one limb, 5 had paralyses of two limbs, 2 had paralyses of three limbs, and 2 had paralyses of four limbs. One of them reported that the disease affected the respiratory system. Of the patients in non-PPS group, 15 had paralyses of one limb, 3 had paralyses of two limbs, and 1 had paralyses of three limbs. None of them had paralyses of four limbs. Also none of them reported that the respiratory system was affected ( Table 1) .
The most common symptoms were fatigue (16 patients, 76.2%), and muscle pain (15 patients, 71.4%) in PPS group. These were followed by sleep disorders (12 patients, 57.14%) and joint pain (11 patients, 52.38%), respectively. Dysphagia and respiratory disorders were noted in one patient (4.76%). In non-PPS group, the most frequent symptoms were muscle pain, fatigue, sleep disorders and joint pain, which were reported in 42.1%, 36.8%, 31.58%, 15.79% of the patients, respectively. Fatigue, joint pain and muscle pain were significantly higher in PPS group (p < 0.05). Total MMT score was 26.19 ± 13.24 (median: 29) in PPS group and 30.08 ± 8.9 (median: 32) in non-PPS group. According to the Mann-Whitney U test, total MMT scores of non-PPS group were significantly higher than that of PPS group (p < 0.05) ( Table 2) . Kruskal-Wallis test revealed that differences among groups were significant in all FSI subgroups (p < 0.05). According to the Mann-Whitney U test, FSI scores of PPS group were significantly higher than that of both non-PPS group and the control group (p < 0.05) ( Table 3) . It was not found any statistically significant difference in BDS scores between PPS, non-PPS and control groups (p > 0.05). Median values of BDS and FSI in patients and the control group are given in Table 3 .
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Kruskal-Wallis test showed that differences among groups were significant in all NHP subgroups except social isolation, emotional reaction and sleep (p < 0.05). According to the Mann-Whitney U test, PPS group scored significantly higher in pain, physical mobility and energy subgroups of NHP than non-PPS and the control group (p < 0.05). It was not reported a statistically significant difference in social isolation, emotional reaction and sleep subgroups. Also non-PPS group reported poorer levels in all NHP groups except social isolation, emotional reaction and sleep subgroups, when compared to the control group (Table 4) . Median values of NHP scores in patients and the control group are given in Table 4 .
Discussion
The aim of this study was to investigate QoL in polio survivors in Turkey in order to assess the impact of PPS on QoL in terms of functional status, severity of pain, social and emotional functioning.
The results showed that PPS impaired QoL including physical mobility, pain and energy, but did not affect emotional and social health. Furthermore it was not found any statistically significant difference in BDS scores between PPS, non-PPS and control groups. This finding confirmed that PPS did not have a negative impact on emotional status. Our results support the previous studies in the literature. It was reported lower scores in physical functioning in 38 post-polio patients in the study of McNaughton et al. where QoL was measured by using Short Form-36 (SF-36). 12 Similarly, Jacob investigated QoL in 101 polio survivors from two post-polio clinics in Israel and reported low physical scores and normal mental scores including emotional and social functioning in post-polio patients. 13 Tate et al. confirmed that polio survivors did not differ from the general population in levels of depression. 14 By contrast, Schanke, 15 Conrady 16 and Hazendonk 17 reported that PPS patients had higher levels of depressive symptoms as compared to control groups. Also On et al. found lower physical, social and emotional scores in PPS group where QoL was evaluated by using NHP. 18 Patients with PPS experienced significantly higher levels of fatigue when compared to non-PPS and control group. This finding supports the previous studies. [18] [19] [20] To our knowledge, this is the first study to evaluate fatigue in polio survivors by using FSI. Fatigue is a complex symptom and it must be assessed by a multidimensional questionnaire which identifies different aspects of fatigue in detail. FSI deals with various characteristics of fatigue and its perceived interference with quality of life in terms of general work activities, ability to concentrate, and enjoyment of life and mood. Furthermore, it states daily patterns of Fatigue. 10, 11 It was suggested as a useful instrument in assessment of fatigue by the reviewers. 21 In previous studies, no significant differences were found in total MMT scores between PPS and non-PPS groups. 18, 22 Contrarily, in our study, total MMT scores of PPS group were significantly lower than that of non-PPS group.
In the present study, the most common symptoms were fatigue (76.2%), and muscle pain (71.4%) in PPS group. This result is in accordance with other clinical studies. In a study by Nollet on disability and functional status in Dutch patients with PPS, 78% of the patients selected fatigue as their major problem. 22 In Conde's study, the most frequent complaints were fatigue (87.1%), muscle pain (82.4%), and joint pain (72%). 23 We found that prevalence of fatigue, joint pain and muscle pain was significantly higher in PPS group than non-PPS group. Prevalence of sleep disorders was similar in both of the groups. 57% of PPS patients had sleep disorders. In the study of van Kralingen, prevalence of sleep disorders was found as 50%. 24 Östlund reported that post polio related fatigue had a negative effect on sleep quality. 25 Contrarily, in our study, fatigue did not influence NHP sleep scores.
The small sample size deemed our main limitation. It is due to the exclusion of concomitant medical and psychiatric diseases that may cause fatigue.
As a conclusion, PPS has a negative impact on QoL in terms of functional status, severity of pain and energy. Thus, early recognition and complex rehabilitation in the beginning of PPS may result in an increase in QoL in polio survivors. Also identifying postpolio-related fatigue and then reducing it may be an additional strategy in improving QoL. Since FSI is a multidimensional questionnaire that presents different aspects of fatigue, it should take place in clinical practice. 
